FIELD: medicine.
SUBSTANCE: blood plasma is analysed for a cardiolipin antibody level. If at least two studies has shown an upper limit of the reference blood plasma cardiolipin antibody limits exceeded by 10-20%, the one-vascular stenotic lesion is predicted. The multivascular stenotic bed lesion is proven by at least two studies showing an upper limit of the reference blood plasma cardiolipin antibody limits exceeded by more than 21%.
EFFECT: use of the method allows predicting a severity of bed lesion in a patient, sizing the possibilities of subsequent treatment.
4 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF DEVELOPING IRREVERSIBLE GRAFT DYSFUNCTION IN CARDIAC RECIPIENTS | 2012 |
|
RU2493567C1 |
METHOD FOR DETERMINING MITOCHONDRIAL MYOCARDIAL DYSFUNCTION FOLLOWING CARDIAC TRANSPLANTATION USING RADIONUCLIDE METHOD | 2018 |
|
RU2687584C1 |
METHOD OF DIAGNOSIS OF AFFECTION OF CORONARY BED | 2000 |
|
RU2180520C1 |
METHOD OF DIAGNOSTICS OF MULTIVASCULAR ATHEROSCLEROTIC DAMAGE OF CORONARY ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH ABDOMINAL OBESITY | 2018 |
|
RU2677280C1 |
METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
METHOD OF ASSESSING THE PROBABILITY OF ATROPHIC GASTRITIS IN PATIENTS WITH CHRONIC CORONARY HEART DISEASE | 2022 |
|
RU2806066C2 |
METHOD FOR PREDICTION OF SMALL CARDIAC OUTPUT SYNDROME AFTER CORONARY BYPASS SURGERY | 2023 |
|
RU2815149C1 |
METHOD FOR REVASCULARISATION OF MULTIPLE CORONARY BED LESION ACCOMPANYING ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2013 |
|
RU2544096C1 |
METHOD OF CHRONIC CARDIAC INSUFFICIENCY MEDICAL TREATMENT | 2006 |
|
RU2325934C1 |
METHOD FOR INDUCTION OF EXTRACARDIAL MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH CORONARY HEART DISEASE | 2021 |
|
RU2758024C1 |
Authors
Dates
2011-08-10—Published
2010-04-05—Filed